The Institute of Trichologists

Dupilumab in Alopecia Areata

PROFESSOR ANDREW MESSENGER MD FRCP There are an increasing number of case reports and small case series describing hair regrowth following treatment with the monoclonal antibody drug dupilumab. Dupilumab is licensed for treating atopic dermatitis and the original observations were serendipitous in patients who happened to have alopecia areata as well as dermatitis. Although there

Dupilumab in Alopecia Areata Read More »

Following historical “tracks” of hair follicle miniaturisation in patterned hair loss: Are elastin bodies the forgotten aetiology?

May 2021 The Institute of Trichologists’  Member Dr Hugh Rushton collaborated in a  study that followed historical “tracks” of hair follicle miniaturisation in patterned hair loss. ABSTRACT: Pattern hair loss (PHL) is a chronic regressive condition of the scalp, where follicular miniaturisation and decreased scalp hair coverage occurs in affected areas. In all PHL cases,

Following historical “tracks” of hair follicle miniaturisation in patterned hair loss: Are elastin bodies the forgotten aetiology? Read More »

Shedding light on therapeutics in alopecia and their relevance to COVID-19

December 2020 The Institute of Trichologists’  President Professor Andrew Messenger collaborated in a  study that reported on therapeutics in alopecia and their relevance to COVID-19. ABSTRACT: As of July 9, 2020, there were more than 12 million confirmed cases of coronavirus disease 2019 (COVID-19) across the globe, with more than 550,000 deaths. Many European countries, including Belgium,

Shedding light on therapeutics in alopecia and their relevance to COVID-19 Read More »

Annual Psychodermatology UK Seminar at the Royal College of Physicians, London

Thursday 26th January 2017 Board Members Anita Ashcroft, Tracey Walker, Deborah Heal, Lisa Gilbey and former Vice Chair Barbara Kemp attended this annual event at this prestigious venue. Many of today’s lectures were about the psychology side of patients experiencing many skin conditions, such as eczema and psoriasis. It was noted that one-third of all

Annual Psychodermatology UK Seminar at the Royal College of Physicians, London Read More »